Kumar Neil

CIK 00017424855 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001742485

Recent Transactions

50 trades

Award
BridgeBio Oncology Therapeutics, Inc.$BBOT
Stock Option (Right to Buy)
2026-06-16+31,675→ 31,675 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-06-05$67.20/sh−7,148→ 4,331,299 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-06-05$68.96/sh−4,416→ 515,686 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-06-05$67.88/sh−8,437→ 520,102 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-06-05$67.88/sh−8,437→ 4,322,862 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-06-05$68.96/sh−4,415→ 4,318,447 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-06-05$67.20/sh−7,147→ 528,539 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-06-04$66.72/sh−1,429→ 4,354,818 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-06-04$65.72/sh−2,200→ 4,356,247 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-06-04$68.27/sh−450→ 535,686 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-06-04$65.72/sh−2,200→ 553,486 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-06-04$67.74/sh−15,921→ 536,136 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-06-04$66.72/sh−1,429→ 552,057 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-06-04$67.74/sh−15,921→ 4,338,897 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-06-04$68.27/sh−450→ 4,338,447 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-05-21$69.22/sh−5,072→ 255,377 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-05-21$70.48/sh−11,250→ 244,127 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-05-21$70.92/sh−800→ 243,327 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-05-21$68.30/sh−6,725→ 260,449 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-05-21$67.57/sh−2,256→ 267,174 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Restricted Stock Units
2026-05-16−33,544→ 100,632 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Restricted Stock Units
2026-05-16−6,519→ 97,794 total
Tax Payment
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-05-16$66.13/sh−36,236→ 269,430 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-05-16+19,599→ 287,594 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-05-16+11,553→ 299,147 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-05-16+6,519→ 305,666 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Restricted Stock Units
2026-05-16−19,599→ 137,195 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-05-16+33,544→ 267,995 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Restricted Stock Units
2026-05-16−11,553→ 127,092 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-05-08$66.65/sh−13,974→ 4,364,473 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-05-08$66.65/sh−13,973→ 561,713 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-05-08$67.35/sh−5,077→ 556,636 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-05-08$67.35/sh−5,076→ 4,359,397 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-05-08$68.35/sh−950→ 4,358,447 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-05-08$68.35/sh−950→ 555,686 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-05-07$69.09/sh−449→ 4,378,447 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-05-07$68.38/sh−8,334→ 4,378,896 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-05-07$68.38/sh−8,333→ 576,136 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-05-07$69.09/sh−450→ 575,686 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-05-07$67.50/sh−11,217→ 584,469 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-05-07$67.49/sh−11,217→ 4,387,230 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-04-10$74.60/sh−20,000→ 595,686 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-04-10$74.60/sh−20,000→ 4,398,447 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-04-09$74.57/sh−5,128→ 4,426,247 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-04-09$75.53/sh−7,800→ 4,418,447 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-04-09$74.60/sh−5,300→ 623,186 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-04-09$75.55/sh−7,500→ 615,686 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-04-09$73.64/sh−7,200→ 628,486 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-04-09$73.64/sh−7,072→ 4,431,375 total
Award
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2026-03-27+33,417→ 33,417 total

Companies

Recent Filings

Address

BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. 256 EAST GRAND AVENUE, SUITE 104

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov